Frontlight ResearchEarly access
Trial site
OptumCare Cancer Care
- 2running trials
- 7closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Colorectal cancer2 trials
- Head and neck cancer2 trials
- Melanoma2 trials
- Pancreatic cancer2 trials
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 24 trials
- Phase 33 trials
- Phase 1/21 trial
- Status
- Completed5 trials
- Terminated2 trials
- Active, not recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- BioAtla, Inc.2 trials
- NovoCure GmbH2 trials
- Tempus AI2 trials
- Daiichi Sankyo1 trial
- NovoCure Ltd.1 trial
- and 1 more
Running trials
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
Closed trials
Terminated
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
Completed
Terminated
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026